Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
about
Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosisAntifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosisAzoles for allergic bronchopulmonary aspergillosis associated with asthmaAzoles for allergic bronchopulmonary aspergillosis associated with asthmaEffect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjectsAspergillus fumigatus and aspergillosisSuccessful Treatment of Allergic Bronchopulmonary Aspergillosis With Isavuconazole: Case Report and Review of the LiteratureComparison of Steroid and Itraconazole for Prevention of Recurrence in Allergic Fungal Rhinosinusitis: A Randomized Controlled TrialPractice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America.Allergic bronchopulmonary aspergillosis: new concepts of pathogenesis and treatment.Allergic bronchopulmonary aspergillosis: a review of a disease with a worldwide distribution.In vitro susceptibilities to amphotericin B, itraconazole, and miconazole of filamentous fungi isolated from patients with cystic fibrosisRecommendations for the treatment of fungal pneumonias.Molecular detection of Schizophyllum commune in a case of allergic fungal rhinosinusitis.Pulmonary Schizophyllum commune infection developing mucoid impaction of the bronchi.Severe asthma with fungal sensitization.Oral antifungal therapy for chronic rhinosinusitis and its subtypes: a systematic review.Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.Clinical pharmacokinetics and pharmacodynamics of prednisolone and prednisone in solid organ transplantation.Phenotyping airways disease: an A to E approach.Allergic bronchopulmonary mycosis due to fungi other than Aspergillus: a global overview.Antifungal treatment in allergic bronchopulmonary aspergillosis with and without cystic fibrosis: a systematic review.Antibody testing in aspergillosis--quo vadis?Treatment of aspergillosis with itraconazole.The spectrum of allergic fungal diseases of the upper and lower airways.Commentary: unusual manifestations of aspergillosisAllergic bronchopulmonary aspergillosis in asthma: epidemiological, clinical and therapeutic issues.Sputum itraconazole concentrations in cystic fibrosis patients.Bioassay for serum itraconazole concentrations using hydroxyitraconazole standards.Reply to "implications of high antifungal susceptibility on Schizophyllum commune-associated allergy in clinical practice".Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.Randomized controlled trial of oral antifungal treatment for severe asthma with fungal sensitization: The Fungal Asthma Sensitization Trial (FAST) study.Pharmacokinetics of oral posaconazole in neutropenic patients receiving chemotherapy for acute myelogenous leukemia or myelodysplastic syndrome.Pharmacokinetics of oral posaconazole in allogeneic hematopoietic stem cell transplant recipients with graft-versus-host disease.Severe small airways disease resistant to medical treatment in a child with cystic fibrosis.What is the current place of azoles in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization
P2860
Q24187765-257F30A3-4EC4-4503-9E08-A071AD4438E6Q24202783-573ECCBA-D91A-4706-B1A0-7A4C82AF9DE2Q24246695-B82F3839-68FD-4D93-B6D1-AB9DDEB7F028Q24250156-DE311D22-79B9-470C-BC19-7B8655D0A53DQ28367515-F0B2F6CB-70B9-4AA0-8BDC-9DDF899D954BQ29617908-F757A569-CA3A-4FE5-9A4E-DD6D617FABC0Q33641883-106060B8-D659-49F9-9A7D-3C084C183805Q33741707-8F538308-7D11-4660-B937-7ADAC9A78652Q33894472-33DBC979-A79F-4821-830A-8A445E9A5F68Q34192961-D74D4DAD-FA97-403A-B48B-43993AE9D25BQ34719251-FB1F788D-96D6-47EF-AF24-D14A8DB22788Q35138343-F3BD3BD4-05BE-4850-87E6-7B9D1EB393B7Q35183728-7B55BB82-3706-4966-9C60-CBE53D491EA4Q35691703-4CD07F4C-9253-4B3B-8729-F00B6EC672C9Q36470394-5265E993-6BBB-47D0-BC45-E40B9DE5B982Q37905686-2E7BF7A3-7A2B-4509-8C5D-2B55F9EE72B3Q37979762-0137B9CC-00AD-4C96-9151-81B03C3AC815Q37989562-AC0C5E30-FD3B-4C76-98EA-93D8E653DD4BQ38047203-CC2C1ADD-8F02-4A23-AB46-A71C4C99E37AQ38062584-F69A3185-B0A5-4B27-A433-2027A8E72F44Q38079263-150B6D3F-22AF-4F91-8C28-2BE5A93ECDCDQ38210276-20D1CF93-4E3C-4B55-8D70-83FA19B2F04EQ38484090-3A817EE6-9D6D-430E-B1E5-DD663DFDB7B6Q38567823-809828BA-7EE1-4811-92FB-471A8EDD8C80Q38699838-F24C4BBA-DE53-47B5-A335-1A0AFEA9960BQ38970354-3ECDE6CE-3BE2-4A1A-900F-1EABDD9EE480Q39319765-DD43CBB6-6066-45B3-BF03-FB94418FBFF4Q39477646-A6FD08F2-0A04-4315-8CB9-E86D0919A4E3Q40285846-66998223-8A03-412B-8F98-62E2777409DCQ42930511-D5F57121-7B4E-40B4-8D28-FD5173B23339Q44066338-7525CD80-AD8B-48B8-A287-9ED47ADF5CFFQ46299846-EC97CFCB-EDB3-41ED-ACDB-E6DA9797329DQ46341880-911A3804-B8AE-4C21-BDD0-9378CBD78E0AQ46879963-3C10EC27-81D0-45AF-A988-759BFDAE38E1Q55664880-7B1F7CAC-771E-4B21-8645-27BE9FA36143Q57749749-EA82E232-139E-44D2-84FE-B0236A0B80E6
P2860
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh
1991年學術文章
@zh-hant
name
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
@en
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
@nl
type
label
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
@en
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
@nl
prefLabel
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
@en
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
@nl
P2093
P356
P1433
P1476
Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole.
@en
P2093
Denning DW
Lewiston NJ
Stevens DA
Van Wye JE
P304
P356
10.1378/CHEST.100.3.813
P407
P577
1991-09-01T00:00:00Z